Non-melanoma skin cancer treated with HDR valencia applicator: Clinical outcomes

Journal of Contemporary Brachytherapy

Volumn 6, Issue 2, 2014, Pages 167-172

  Tormo, Alejandro ^a   Celada, Francisco ^a   Rodriguez, Silvia ^b   Botella, Rafael ^a   Ballesta, Antonio ^a   Kasper, Michael ^c   Ouhib, Zoubir ^c   Santos, Manuel ^b   Perez Calatayud, Jose ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Hospital Clinica Benidorm   (Spain)

^c Radiation Oncology Lynn Regional Cancer Center   (United States)

Author keywords

HDR; Skin brachytherapy; Skin cancer; Valencia applicators

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BRACHYTHERAPY; BRACHYTHERAPY DEVICE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; HUMAN; HYPOPIGMENTATION; MALE; NON MELANOMA SKIN CANCER; PATIENT SAFETY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SKIN TOXICITY; TOPICAL TREATMENT; TUMOR VOLUME; VALENCIA APPLICATOR;

EID: 84904602220     PISSN: 1689832X     EISSN: None     Source Type: Journal    
DOI: 10.5114/jcb.2014.43247     Document Type: Article

References (37)

1. Wu TP, Stein JA. Skin Cancer in Young Women. J Drugs Dermatol 2013; 12: 568-572.
2. Rogers HW, Martin A. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146: 283-287.
3. SkinCancerNet: What is skin cancer? Schaumberg, IL: American Academy of Dermatology. Available at: htp://www.skincarephysicians.com/skincancernet/ whatis.html. Accessed March 17, 2012.
4. Lo A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069-1080.
5. Lovett RD, Perez CA, Shapiro SJ et al. External radiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 1990; 19:235-242. (Pubitemid 20299013)
6. Bhatnagar A. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year. Brachytherapy 2013; 12: 134-140.
7. Kohler-Brock A, Pragger W. The indications for and results of HDR afterloading therapy in diseases of the skin and mucosa with standardized surface applicators (the Leipzig Applicator). Strahlenther Onkol 1999; 175: 170-174. (Pubitemid 29180593)
8. Guix B, Finestres F, Tello J et al. Treatment of skin carcinomas of the face by high dose rate brachytherapy and custom made surface molds. Int J Radiat Oncol Biol Phys 2000; 47: 95-102. (Pubitemid 30179682)
9. Kowalik L, Lyczek J, Sawicki M et al. Individual applicator for brachytherapy for various sites of superficial malignant lesions. J Contemp Brachytherapy 2012; 5: 45-49.
10. Granero D, Perez-Calatayud J, Jimeno J et al. Design and evaluation of a HDR skin applicator with flattening filter. Med Phys 2008; 35: 495-503. (Pubitemid 351190869)
11. Granero D, Perez-Calatayud J, Ballester F et al. Radiation leakage study for the Valencia applicators. Physica Medica 2013; 29: 60-64.
12. Perez-Calatayud J, Granero D, Ballester F et al. A dosimetric study of the Leipzig applicators. Int J Rad Oncol Biol Phys 2005; 62: 579-584.
13. Niu H, His WC, Chu JCH et al. Dosimetric characteristics of the Leipzig surface applicators used in the high dose rate brachy radiotherapy. Med Phys 2004; 31: 3372-3377. (Pubitemid 40064989)
14. Hwang IM, Lin SY, Lin LC et al. Alternative effective modality of Leipzig applicator with an electron beam for the treatment of superficial malignancies. Nuc Inst Meth A 2003; 508: 460-466.
15. Evans MDC, Yassa M, Podgorsak EB et al. Surface applicators for high dose rate brachytherapy in aids-related Kaposi sarcoma. Int J Radiat Oncol Biol Phys 1997; 39: 769-774. (Pubitemid 27441448)
16. nd ASTRO Annual Meeting. Chicago. November 2009. Skin Cancer. Brachytherapy in Skin Cancer. Panel 8.
17. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.
18. Adam IR, Chen EH, Ratner D. Basal-Cell Carcinoma. N Engl J Med 2005; 353: 2262-2269. (Pubitemid 41697289)
19. Chren MM, Torres JS, Stuart SE et al. Recurrence after treatment of nonmelanoma skin cancer: A prospective cohort study. Arch Dermatol 2011; 147: 540-546.
20. MacFarlane L, Waters A, Evans A et al. Seven years' experience of Mohs micrographic surgery in a UK centre, and development of a UK minimum dataset and audit standards. Clin Exp Dermatol 2013; 8: 262-269.
21. Linos E, Parvataneni R, Stuart SE et al. Treatment of Nonfatal Conditions at the End of Life: Nonmelanoma Skin Cancer. JAMA Intern Med 2013; 173: 1006-1012.
22. Svoboda V, Kovarik J, Morris F. High dose-rate microselectron molds in the treatment of skin tumors. Int J Radiat Oncol Biol Phys 1995; 31: 967-972.
23. Allan E, Stanton A, Pye D et al. Fractionated high dose rate brachytherapy moulds: a precise treatment for carcinoma of the pinna. Radiother Oncol 1998; 48: 277-281. (Pubitemid 28555661)
24. Chan A, D'Souza O, Vujovic G et al. High dose rate (HDR) brachytherapy treatment for skin cancer: a novel approach. Int J Radiat Oncol Biol Phys 2003; 57 (2), Supplement.
25. Ghaly M, Birnes R, Musmacher J et al. HDR Brachytherapy with standardized surface applicators (the Leipzig applicator) as an alternative, radiotherapy treatment for superficial malignant skin lesions. Int J Radiat Oncol Biol Phys 2006; 66 (3) Supplement.
26. Fabrini MG, Perrone F, De Liguoro M et al. High dose rate brachytherapy in a large squamous cell carcinoma of the hand. Brachytherapy 2008; 7: 270-275.
27. Gauden S, Egan C, Pracy M. HDR brachytherapy for the treatment of skin cancers using standard surface applicators. Brachytherapy 2008; 7: s159 (abstract).
28. Montero A, Hernanz R, Capuz AB et al. High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer. Clin Transl Oncol 2009; 11: 760-764.
29. Kanikowski M. HDR brachytherapy of skin cancer in material of Greater Poland Cancer Center. J Contemp Brachytherapy 2009; 3: 197 (abstract).
30. Maroñas M, Guinot JL, Arribas L et al. Treatment of facial cutaneous carcinoma with high dose rate contact brachytherapy with customized molds. Brachytherapy 2011; 10: 221-227.
31. Ozyar E, Gurdalli S. Mold brachytherapy can be an optional technique for total scalp irradiation. Int J Radiat Oncol Biol Phys 2002; 54: 1286. (Pubitemid 35292643)
32. Ghaly M, Zinkin H, Dannenberg M et al. HDR Brachytherapy with Standardized Surface Applicators in the Treatment of Superficial Malignant Skin Lesions. Int J Radiat Oncol Biol Phys 2008; 72: 505-506 (abstract).
33. Khan L, Choo R, Breen D et al. Recommendations for CTV margins in radiotherapy planning for non melanoma skin cancer. Radiother Oncol 2012; 104: 263-266.
34. Caresana G, Giardini R. Dermoscopy-guided surgery in basal cell carcinoma. J Eur Acad Dermatol Venereol 2010; 24: 1395-1399.
35. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992; 27: 241-248.
36. National Cancer Institute Common Terminology Criteria for Adverse Events v4.0
37. NCI, NIH, DHHS. May 29, 2009. NIH publication # 09-7473. http://ctep.cancer.gov/protocolDevelopment/electronic-applications/ctc.htm